Home
About
Overview
Sharing Data
ORCID
Help
History (1)
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors.
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer. 2024 Sep 23; 12(9).
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
Female
Humans
Isoquinolines
Mice
Neoplasms
Protein-Arginine N-Methyltransferases
Purine-Nucleoside Phosphorylase
Pyrimidines
T-Lymphocytes
authors with profiles
Weiyi Peng
Xinli Liu